Purdue University

Technology for cloud efficiency for databases during data-intensive COVID-19 pandemic

4-Jun-2020 3:05 PM EDT, by Purdue University

Newswise — WEST LAFAYETTE, Ind. - A Purdue University data science and machine learning innovator wants to help organizations and users get the most for their money when it comes to cloud-based databases. Her same technology may help self-driving vehicles operate more safely on the road when latency is the primary concern.

Somali Chaterji, a Purdue assistant professor of agricultural and biological engineering who directs the Innovatory for Cells and Neural Machines [ICAN], and her team created a technology called OPTIMUSCLOUD.

The system is designed to help achieve cost and performance efficiency for cloud-hosted databases, rightsizing resources to benefit both the cloud vendors who do not have to aggressively over-provision their cloud-hosted servers for fail-safe operations and to the clients because the data center savings can be passed on them.

"It also may help researchers who are crunching their research data on remote data centers, compounded by the remote working conditions during the pandemic, where throughput is the priority," Chaterji said. "This technology originated from a desire to increase the throughput of data pipelines to crunch microbiome or metagenomics data."

The Purdue technology works with the three major cloud database providers: Amazon's AWS, Google Cloud, and Microsoft Azure. Chaterji said it would work with other more specialized cloud providers such as Digital Ocean and FloydHub, with some engineering effort.

It is benchmarked on Amazon's AWS cloud computing services with the NoSQL technologies Apache Cassandra and Redis.

"Let's help you get the most bang for your buck by optimizing how you use databases, whether on-premise or cloud-hosted," Chaterji said. "It is no longer just about computational heavy lifting, but about efficient computation where you use what you need and pay for what you use."

Chaterji said current cloud technologies using automated decision making often only work for short and repeat tasks and workloads. She said her team created an optimal configuration to handle long-running, dynamic workloads, whether it be workloads from the ubiquitous sensor networks in connected farms or high-performance computing workloads from scientific applications or the current COVID-19 simulations from different parts of the world in a rush to find the cure against the virus.

"Our right-sizing approach is increasingly important with the myriad applications running on the cloud with the diversity of the data and the algorithms required to draw insights from the data and the consequent need to have heterogeneous servers that drastically vary in costs to analyze the data flows," Chaterji said. "The prices for on-demand instances on Amazon EC2 vary by more than a factor of five-thousand, depending on the virtual memory instance type you use."

The Purdue team's technology has been accepted for publication at the 2020 USENIX Annual Technical Conference, taking place as a virtual event in July.

Chaterji said OPTIMUSCLOUD has numerous applications for databases used in self-driving vehicles (where latency is a priority), health care repositories (where throughput is a priority), and Internet of Things (IoT) infrastructures in farms or factories.

OPTIMUSCLOUD is a software that is run with the database server. It uses machine learning and data science principles to develop algorithms that help jointly optimize the virtual machine selection and the database management system options.

"Also, in these strange times when both traditionally compute-intensive laboratories such as ours and wet labs are relying on compute storage, such as to run simulations on the spread of COVID-19, throughput of these cloud-hosted VMs is critical and even a slight improvement in utilization can result in huge gains," Chaterji said. "Consider that currently, even the best data centers run at lower than 50% utilization and so the costs that are passed down to end-users are hugely inflated."

The other members of the team that developed OPTIMUSCLOUD are Saurabh Bagchi, a Purdue professor of electrical and computer engineering and computer science (by courtesy); Ashraf Mahgoub, a Ph.D. student in computer science; and Karthik Shankar, an undergraduate researcher in Chaterji's lab headed to Carnegie Mellon for graduate school in computer science.

"Our system takes a look at the hundreds of options available and determines the best one normalized by the dollar cost," Chaterji said. "When it comes to cloud databases and computations, you don't want to buy the whole car when you only need a tire, especially now when every lab needs a tire to cruise."

###

The work is supported by the National Institutes of Health through a 5-year R01 grant and a grant from the Wabash Heartland Innovation Network (Lilly Endowment Inc.).

The team worked with the Purdue Research Foundation Office of Technology Commercialization to patent the technology. The office recently moved into the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus.

About Purdue Research Foundation Office of Technology Commercialization

The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities through commercializing, licensing and protecting Purdue intellectual property. The office recently moved into the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus. In fiscal year 2019, the office reported 136 deals finalized with 231 technologies signed, 380 disclosures received and 141 issued U.S. patents. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.

About Purdue University

Purdue University is a top public research institution developing practical solutions to today's toughest challenges. Ranked the No. 6 Most Innovative University in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at purdue.edu.




Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.79808